Abstract
The new type of aortic valved stent designed in this study was characterized with good stability and could avoid the impact caused by valve leaflets on the coronary artery.
Introduction
Aortic valve disease remains a significant cause of cardiovascular mortality, particularly among elderly populations. While Transcatheter Aortic Valve Implantation (TAVI) has revolutionized treatment for high-risk patients, the procedure is still plagued by two critical complications: coronary ostial obstruction and device instability leading to paravalvular leaks. Coronary obstruction occurs when the native leaflets are displaced by the stent, blocking blood flow to the heart muscle—a complication that is often fatal.
This study introduces a novel self-expanding aortic valved stent featuring a sine-curve nitinol frame. This design aims to provide superior radial stability while ensuring that the coronary ostia remain unobstructed during and after deployment.
Methodology
The researchers engineered a stent frame using 0.2 mm super-malleable nitinol wire, specifically shaped into a sine-curve geometry to leverage nitinol's shape-memory properties. The valve component was constructed from fresh porcine pericardium, treated with glutaraldehyde to ensure durability and minimize immunogenicity.
Experimental Setup
The evaluation was conducted in two distinct phases:
- In Vitro Testing: Stents were deployed in PVC tubes and isolated miniature pig hearts (3–4 months old). A circulation system measured transvalvular pressure gradients, effective orifice area (EOA), and regurgitant volumes.
- In Vivo Testing: Six healthy adult pigs (15–21 kg) underwent retrograde TAVI via the femoral artery. Implantation was guided by Digital Subtraction Angiography (DSA) and echocardiography.
Results
The experimental results demonstrated high procedural success and improved hemodynamic performance:
- Hemodynamics: In vitro data showed a statistically significant reduction in aortic regurgitant volumes ($P < 0.05$) following stent placement.
- Coronary Safety: Crucially, coronary artery flow rates showed no significant change after implantation ($P > 0.05$), confirming that the stent architecture does not impede blood flow to the coronary ostia.
- Stability and Survival: Five of the six porcine subjects survived the 24-hour observation period. Post-mortem anatomic evaluations confirmed that the stents remained securely fixed in their intended positions without migration.
- Biocompatibility: Early signs of endothelialization were observed on the stent surfaces within 24 hours, suggesting a favorable long-term integration profile.
Discussion and Limitations
The sine-curve geometry proved effective in maintaining coronary perfusion while providing the necessary radial force for stability. However, the study noted one procedural failure where a stent failed to expand fully, leading to the death of one subject. This highlights the critical importance of the delivery system's reliability.
While promising, the study is limited by its short 24-hour observation window and the use of healthy animal models. Future research must address how these stents interact with the calcified, rigid valves typically found in human patients and evaluate long-term outcomes such as valve calcification and chronic inflammatory responses.
Conclusion
The novel sine-curve nitinol valved stent represents a significant step forward in TAVI technology. By balancing radial stability with a design that preserves coronary flow, this device addresses the primary safety concerns of current transcatheter interventions.
Summary updated